Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa
Top Cited Papers
- 30 January 2007
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 21 (3) , 335-341
- https://doi.org/10.1097/qad.0b013e328011efac
Abstract
Objective: To determine the burden and impact of immune reconstitution disease (IRD) associated with tuberculosis (TB) among patients initiating antiretroviral treatment (ART) in sub-Saharan Africa. Design: Retrospective analysis of a study cohort enrolled over 3 years within a community-based ART service in South Africa. Methods: Patients receiving treatment for TB at the time ART was initiated (n = 160) were studied. Cases of TB-associated IRD during the first 4 months of ART were ascertained. Results: The median baseline CD4 cell count was 68 cells/μl [interquartile range (IQR), 29–133 cells/μl) and ART was initiated after a median of 105 days (IQR, 61–164 days) from TB diagnosis. Although IRD was diagnosed in just 12% (n = 19) of patients overall, IRD developed in 32% (n = 12) of those who started ART within 2 months of TB diagnosis. Pulmonary involvement was observed in 84% (n = 16) and intra-abdominal manifestations were also common (37%). Overall, 4% (n = 7) of the cohort required secondary level health-care for IRD and two (1%) patients died. In multivariate analysis, risk of IRD was strongly associated with early ART initiation and low baseline CD4 cell count. Of patients with CD4 counts < 50 cells/μl, the proportions who developed IRD following initiation of ART within 0–30, 31–60, 61–90, 91–120 and > 120 days of TB diagnosis were 100%, 33%, 14%, 7% and 0%, respectively. Conclusions: The risk of TB-associated IRD in this setting is very high for those with low baseline CD4 cell counts initiating ART early in the course of antituberculosis treatment. However, most cases were self-limiting; overall secondary health-care utilization and mortality risk from IRD were low.Keywords
This publication has 22 references indexed in Scilit:
- Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis controlAIDS, 2006
- Impact of HIV Infection on the Epidemiology of Tuberculosis in a Peri-Urban Community in South Africa: The Need for Age-Specific InterventionsClinical Infectious Diseases, 2006
- Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme designAIDS, 2005
- Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretroviralsPublished by Elsevier ,2005
- Determinants of Immune Reconstitution Inflammatory Syndrome in HIV Type 1–Infected Patients with Tuberculosis after Initiation of Antiretroviral TherapyClinical Infectious Diseases, 2004
- Clinical Management of Tuberculosis in the Context of HIV InfectionAnnual Review of Medicine, 2004
- The Growing Burden of TuberculosisArchives of internal medicine (1960), 2003
- Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapyAIDS, 2002
- Treatment of HIV-related Tuberculosis in the Era of Effective Antiretroviral TherapyAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Tuberculosis in Patients with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1999